AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.
1995
40
LTM Revenue $0.7M
LTM EBITDA -$3.1M
$40.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of August 2025, AnteoTech reported last 12-month revenue of $0.7M and EBITDA of -$3.1M.
In the same period, AnteoTech achieved -$3.8M in LTM net income.
See AnteoTech valuation multiples based on analyst estimatesIn the most recent fiscal year, AnteoTech reported revenue of $0.6M and EBITDA of -$5.3M.
AnteoTech expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See AnteoTech valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $0.7M | XXX | $0.6M | XXX | XXX | XXX |
Gross Profit | n/a | XXX | $0.6M | XXX | XXX | XXX |
Gross Margin | n/a | XXX | 100% | XXX | XXX | XXX |
EBITDA | -$3.1M | XXX | -$5.3M | XXX | XXX | XXX |
EBITDA Margin | -416% | XXX | -839% | XXX | XXX | XXX |
EBIT | -$3.8M | XXX | -$6.1M | XXX | XXX | XXX |
EBIT Margin | -512% | XXX | -955% | XXX | XXX | XXX |
Net Profit | -$3.8M | XXX | -$4.4M | XXX | XXX | XXX |
Net Margin | -510% | XXX | -698% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AnteoTech has current market cap of AUD 62.7M (or $41.1M), and EV of AUD 62.4M (or $40.9M).
As of September 12, 2025, AnteoTech's stock price is AUD 0 (or $0).
See AnteoTech trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$40.9M | $41.1M | XXX | XXX | XXX | XXX | $-0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAnteoTech's trades at 87.2x EV/Revenue multiple, and -6.3x EV/EBITDA.
See valuation multiples for AnteoTech and 15K+ public compsAs of September 12, 2025, AnteoTech has market cap of $41.1M and EV of $40.9M.
Equity research analysts estimate AnteoTech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AnteoTech has a P/E ratio of -10.8x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $41.1M | XXX | $41.1M | XXX | XXX | XXX |
EV (current) | $40.9M | XXX | $40.9M | XXX | XXX | XXX |
EV/Revenue | 54.5x | XXX | 87.2x | XXX | XXX | XXX |
EV/EBITDA | -13.1x | XXX | -6.3x | XXX | XXX | XXX |
EV/EBIT | -10.6x | XXX | -5.7x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | -10.8x | XXX | -8.0x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -9.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAnteoTech's last 12 month revenue growth is 74%
AnteoTech's revenue per employee in the last FY averaged $16K, while opex per employee averaged $0.2M for the same period.
AnteoTech's rule of 40 is -1315% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AnteoTech's rule of X is -231% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for AnteoTech and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 74% | XXX | 83% | XXX | XXX | XXX |
EBITDA Margin | -416% | XXX | -1389% | XXX | XXX | XXX |
EBITDA Growth | -82% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | -1315% | XXX | -1315% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | -231% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $16K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 66% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 64% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 1055% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AnteoTech acquired XXX companies to date.
Last acquisition by AnteoTech was XXXXXXXX, XXXXX XXXXX XXXXXX . AnteoTech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was AnteoTech founded? | AnteoTech was founded in 1995. |
Where is AnteoTech headquartered? | AnteoTech is headquartered in Australia. |
How many employees does AnteoTech have? | As of today, AnteoTech has 40 employees. |
Is AnteoTech publicy listed? | Yes, AnteoTech is a public company listed on ASX. |
What is the stock symbol of AnteoTech? | AnteoTech trades under ADO ticker. |
When did AnteoTech go public? | AnteoTech went public in 2000. |
Who are competitors of AnteoTech? | Similar companies to AnteoTech include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of AnteoTech? | AnteoTech's current market cap is $41.1M |
What is the current revenue of AnteoTech? | AnteoTech's last 12 months revenue is $0.7M. |
What is the current revenue growth of AnteoTech? | AnteoTech revenue growth (NTM/LTM) is 74%. |
What is the current EV/Revenue multiple of AnteoTech? | Current revenue multiple of AnteoTech is 54.5x. |
Is AnteoTech profitable? | Yes, AnteoTech is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of AnteoTech? | AnteoTech's last 12 months EBITDA is -$3.1M. |
What is AnteoTech's EBITDA margin? | AnteoTech's last 12 months EBITDA margin is -416%. |
What is the current EV/EBITDA multiple of AnteoTech? | Current EBITDA multiple of AnteoTech is -13.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.